Development and manufacture of and trade in medicinal products and pharmaceuticals (in particular for the treatment of skeletal problems in humans and animals) as well as all other products in the field of human and veterinary medicine and hospital hygiene. The company may establish branches and subsidiaries in Switzerland and abroad, participate in companies with the same or similar purpose, take over representations, acquire, sell, encumber and rent properties, and provide direct or indirect financing to its direct or indirect subsidiaries and third parties, including its direct or indirect shareholders and their direct or indirect subsidiaries, for its own liabilities and those of other companies (including direct or indirect shareholders of the company or companies in which these shareholders are directly or indirectly involved), provide securities of all kinds, including by way of pledges on or fiduciary transfers or assignments of the company's assets, or provide guarantees, enter into sureties or otherwise secure or guarantee the company's or these other companies' obligations, whether for consideration or not. Furthermore, the company may engage in liquidity balancing/concentration of net liquidity (cash pooling) with the aforementioned companies or join such an arrangement, including periodic account balancing. The company may also do all of the above without consideration, on preferential terms, without interest, excluding the company's profit motive, and assuming cluster risks.